Date(s)

22 Jul 2024

Location

Munich, Germany

Leveraging Innovations to End the HIV Pandemic | Satellite Symposium at AIDS 2024

Related Enduring Materials

Enduring Materials

Monday, 22 July

Session 1: Current Tools -

Opening & Welcome

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

30 Years of Innovations: Their Role in the Current Success of ARV Therapy

Sharon Lewin, AO, FRACP, PhD, FAHMS

Peter Doherty Institute for Infection and Immunity, Australia

Video

Slideset

Long Acting PrEP- Clinical Trials and Real World Data

Jürgen Rockstroh, MD

University of Bonn, Germany

Video

Slideset

Long Acting ARV Therapy- Clinical Trials and Real World Data

Chloe Orkin, MBChB, FRCP, MD

Queen Mary University of London, United Kingdom

Video

Meeting the Challenge: Long Acting ARV in Difficult to Treat PLWHIV

Monica Gandhi, MD, MPH

University of California San Francisco, United States

Video

Slideset

Round Table Discussion: Innovations in HIV Care- Looking to the Future

François Venter, MD, FCP, PhD

Ezintsha, University of the Witwatersrand, South Africa

Monica Gandhi, MD, MPH

University of California San Francisco, United States

Angelina Namiba, BA Hons

4MNetwork of Mentor Mothers, United Kingdom

Ndivhuwo Rambau

Ritshidze, South Africa

Video

Closing Remarks / Key Messages

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

General

What's New?

We are happy to announce that "Leveraging Innovations to End the HIV Pandemic" symposium at AIDS 2024 was held as a hybrid symposium on Monday 22 July 22 2024, from 15:00 - 16:30 CEST.
AIDS 2024, the 25th Internation AIDS Conference took place at Messe München: the Trade Fair Center Messe München and the ICM – International Congress Center Messe München, in Munich, Germany.
To stay updated on the relevant developments, make sure you are signed up for our newsletter.

About this Program

Over the past decades, the landscape of HIV medicine has evolved dramatically, ushering in transformative advancements across diagnosis, treatment, and prevention.

Injectable ART has revolutionized treatment and prevention options, offering patients and providers newfound flexibility and efficacy. However, to fully harness the potential of these innovations, continuous education and training for healthcare providers is essential. Equally crucial is empowering patients with comprehensive understanding through innovative approaches to education.

Our symposium, "Leveraging Innovations to End the HIV Pandemic," serves as a beacon for healthcare providers seeking to stay at the cutting edge of HIV care. Through engaging discussions and comprehensive insights, participants will gain a deep understanding of the latest breakthroughs and learn how to seamlessly integrate them into clinical practice.

By fostering collaboration and embracing patient-centered strategies, we aim to propel the field forward, reducing transmission rates and enhancing the quality of life for individuals living with HIV.

Program Chair

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

General Information

Who Should Attend?

Clinicians and allied healthcare professionals caring for PLWHIV, as well as clinical virologists, researchers, immunologists, policymakers, NGO representatives, community advocates, and all other relevant stakeholders.

Learning Objectives

After participating in this activity, participants will be able to:

- Identify how innovations in ARV therapy have shaped HIV care in the past and identify how to continue to integrate innovations into the future of clinical practice.
- Describe current data regarding the use of long-acting ARV for HIV prevention and treatment.
- Gain a better understanding of how to utilize long-acting ARV to improve HIV prevention and treatment.
- Learn from successful examples of innovation implementation in HIV care.
- Highlight a holistic view of embracing innovation in all aspects of HIV prevention and care, considering the spectrum of challenges faced by clinicians and the community.

Practical Information

Accommodation

Accommodation is not included in the registration fee.

Badges

All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.

Language

The official language of the conference/meeting/workshop is English
Translation will/will not be provided.

Disclaimer

This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.

Liability and Insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Committees

Program Chair

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Support

The Leveraging Innovations to End the HIV Pandemic symposium is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or the selection of faculty for this educational activity.

Accreditation

Accreditation Statement

The Leveraging Innovations to End the HIV Pandemic, Munich, Germany, Germany 22/07/2024 - 22/07/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College
of Physicians and Surgeons of Canada.